Life Science Nation Newsletter | May 31, 2018 | Issue 268

  The LSN Story   |   Investor Platform   |   Company Platform   |   RESI Conference   |   Fundraising Consulting
Life Science Investor Mandates (May 24 - May 30 )
Invests Up to $10M Into Early-Stage Therpaeutics, Devices, and Tools Companies
Invests in Therapeutics and Digital Health, With Strong Interests in Small Molecule Therapies in Inflammation, Infectious, Autoimmune Diseases
Makes Pre-Seed/Seed Investments in Data-Driven Technologies Including AI, Drug Discovery, and Computational Biotech
Invests in Early to Growth Stage Biotech Companies with Large Market Potential in China
In This Issue
Nature BioEntrepreneur Features LSN: Aligning Needs
LSN Services
LSN's Sourcing & Ranking Service (SRS) provides clients with an opportunity to quickly source, vet, rank and engage with partners that are licensing global technology assets.

Click to see investors that are a fit for your product and stage of development

Click here if you are a service provider and want to see a list of funded life science companies that are a fit for you

Click here if you want to receive free, targeted early stage dealflow for your life science investment firm

Free Copy of LSN's Book

LSN Videos
Program Guide Is Here!
By Nono Hu, Director of Marketing, LSN

In 4 days, The Redefining Early Stage Investments (RESI) Conference will kick off a bustling week for the global healthtech industry in Boston. At RESI Boston, over 300 investors will be under one roof in search of compelling connections with early stage companies.

Check out the program guide now to plan for a productive day at RESI packed with partnering meetings, innovative technologies, and up-to-date investment knowhow.

See you at RESI on June 4th at the Boston Marriott Copley Place!

By Dennis Ford, Founder & CEO, Life Science Nation; Creator of RESI Conference Series & First Coast Healthtech Week

The inaugural First Coast Healthtech Week (FCHW) launches on September 5th at the Boston Marriott Copley Place with a new conference - the Healthcare Innovators Gathering, where incubators, accelerators, tech transfer, university translation initiatives, hospitals, research labs and their constituents from DC, MD, PA, NJ, NY, RI, CT and MA (the first coast) will gather for the first time in one location to get on the radar screens of potential global partners. The Healthcare Innovators Gathering is followed by the RESI Global Partnering Conference, September 6th, and the Entrepreneurs Academy Workshop Series, September 7th.

LSN's established network of early stage global investors attend RESI Conference Series to source, engage and allocate funds to startup firms across the silos of biotech, medtech, diagnostics, and digital health...

By Christine A. Wu, Senior Research Analyst, LSN

While mental and behavioral health conditions are highly prevalent, they are also often stigmatized. In the healthcare technology arena, this indication area has been on the rise in both excitement and innovation. According to the World Health Organization, one out of four people in the world suffer from a mental or neurological disorder, including a total of about 450 million people with mental disorders. Even as one of the leading causes of ill-health and disability worldwide, mental illness carries with it stigma, discrimination, and neglect, preventing patients from admitting the need for help, reaching for help or having the accessibility to resources for when they do. In a society that shies away from vulnerability, it becomes easy for us to not embrace the need for mental health or fully understand how to prevent future cases.

Moderated by Julie Papanek Grant, Partner at Canaan Partners, the panel includes:
  • Justin Baker, Scientific Director, The McLean Institute for Technology in Psychiatry
  • Ken Duckworth, Senior Medical Director for Behavioral Health, Blue Cross Blue Shield of MA
  • Robert Garber, Partner, 7wire Ventures
  • Eric Schaeffer, Senior Director, Neuroscience Innovation, Johnson & Johnson Innovation

Created & Produced by